Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.91)
# 3,130
Out of 4,918 analysts
790
Total ratings
33.37%
Success rate
-8.65%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics | Downgrades: Neutral | n/a | $0.36 | - | 23 | Jul 30, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $154.17 | +55.67% | 32 | Jul 25, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $77 → $24 | $8.06 | +197.77% | 24 | Jul 11, 2025 | |
| TVTX Travere Therapeutics | Assumes: Buy | $30 | $15.23 | +97.04% | 1 | Jul 1, 2025 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $13 | $1.05 | +1,138.10% | 32 | Jul 1, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Buy | $42 | $14.24 | +194.94% | 1 | Jun 30, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $32.63 | +212.60% | 33 | Jun 25, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $14 | $2.33 | +502.15% | 2 | Jun 25, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $41 → $53 | $63.56 | -16.61% | 2 | Jun 24, 2025 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $1.10 | +265.30% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.64 | +143.90% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.01 | +795.52% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.63 | +537.04% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.37 | +1,072.16% | 29 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $3.63 | +65.52% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.80 | +585.11% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $22.04 | +126.86% | 35 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $6.59 | +142.79% | 20 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.28 | +681.25% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $4.57 | +665.86% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.45 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $24.36 | +326.85% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.47 | +264.37% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.64 | +939.76% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $10.05 | +218.41% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $15 | $0.39 | +3,796.10% | 15 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.00 | +434.22% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $6.89 | +3,528.45% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $2.64 | +659.01% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.73 | +1,133.38% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.59 | +1,032.08% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $6.87 | +118.34% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.90 | +577.97% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.66 | +661.96% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.91 | +724.74% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $37.09 | +223.54% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $7.28 | +119.78% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.22 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $3.45 | +798.55% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.91 | +1,218.68% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.74 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $11.00 | +236.36% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.87 | +488.24% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $21.41 | +166.23% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $7.99 | +162.83% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.76 | +1,039.60% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.10 | +1,090.48% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.52 | +495.90% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.82 | +1,328.57% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.83 | +552.74% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.44 | +6,844.44% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.04 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.88 | +1,602.13% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.95 | +1,442.42% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.51 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $35.39 | -6.75% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.07 | +1,186.07% | 1 | Mar 24, 2017 |
VYNE Therapeutics
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Krystal Biotech
Jul 25, 2025
Reiterates: Buy
Price Target: $240
Current: $154.17
Upside: +55.67%
Capricor Therapeutics
Jul 11, 2025
Maintains: Buy
Price Target: $77 → $24
Current: $8.06
Upside: +197.77%
Travere Therapeutics
Jul 1, 2025
Assumes: Buy
Price Target: $30
Current: $15.23
Upside: +97.04%
PDS Biotechnology
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.05
Upside: +1,138.10%
Edgewise Therapeutics
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $14.24
Upside: +194.94%
Viking Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $102
Current: $32.63
Upside: +212.60%
Phio Pharmaceuticals
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.33
Upside: +502.15%
Cidara Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $63.56
Upside: -16.61%
Lexicon Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.10
Upside: +265.30%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.64
Upside: +143.90%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.01
Upside: +795.52%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.63
Upside: +537.04%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $1.37
Upside: +1,072.16%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $3.63
Upside: +65.52%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.80
Upside: +585.11%
Jun 16, 2025
Reiterates: Buy
Price Target: $50
Current: $22.04
Upside: +126.86%
Jun 13, 2025
Reiterates: Buy
Price Target: $16
Current: $6.59
Upside: +142.79%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $4.57
Upside: +665.86%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $24.36
Upside: +326.85%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.47
Upside: +264.37%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.64
Upside: +939.76%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $10.05
Upside: +218.41%
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.39
Upside: +3,796.10%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $3.00
Upside: +434.22%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $6.89
Upside: +3,528.45%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $2.64
Upside: +659.01%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.73
Upside: +1,133.38%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.59
Upside: +1,032.08%
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $6.87
Upside: +118.34%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $5.90
Upside: +577.97%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +661.96%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.91
Upside: +724.74%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $37.09
Upside: +223.54%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $7.28
Upside: +119.78%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.22
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.45
Upside: +798.55%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.91
Upside: +1,218.68%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.74
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $11.00
Upside: +236.36%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.87
Upside: +488.24%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $21.41
Upside: +166.23%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $7.99
Upside: +162.83%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.76
Upside: +1,039.60%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.10
Upside: +1,090.48%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.52
Upside: +495.90%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.82
Upside: +1,328.57%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.83
Upside: +552.74%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.44
Upside: +6,844.44%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.04
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.88
Upside: +1,602.13%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.95
Upside: +1,442.42%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.51
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $35.39
Upside: -6.75%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.07
Upside: +1,186.07%